Status:
TERMINATED
Effectiveness of the Diabetes Body Project Among Females With Type 1 Diabetes
Lead Sponsor:
Oslo University Hospital
Collaborating Sponsors:
The Dam Foundation
Norwegian Diabetes Association
Conditions:
Feeding and Eating Disorders
Diabetes Mellitus, Type 1
Eligibility:
FEMALE
16-35 years
Phase:
NA
Brief Summary
Young females with type 1 diabetes (T1D) is at high risk of eating disorders (ED), with prevalence rates of ED more than double those of non-diabetes peers. T1D and ED are both associated with serious...
Detailed Description
Type 1 Diabetes (T1D) T1D is caused by an autoimmune destruction of the insulin-producing beta cells in the pancreas, leading to complete lack of insulin. Insulin is necessary to regulate blood glucos...
Eligibility Criteria
Inclusion
- Female, 16-35 years, type 1 diabetes, acknowledges at least some level of body image concerns
Exclusion
- Other forms of diabetes, males
Key Trial Info
Start Date :
February 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2022
Estimated Enrollment :
58 Patients enrolled
Trial Details
Trial ID
NCT04837989
Start Date
February 1 2021
End Date
July 31 2022
Last Update
August 4 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oslo Unviersity Hospital
Oslo, Norway, 0424